Company file
keyboard_backspaceBack to directoryIdentity
Etablissement Français du Sang
The EFS is the sole player in transfusion in France. In addition to its activities of collection, preparation, qualification and distribution of Labile Blood Products (PSL), EFS is a major player in cell and tissue therapies and in the design and production of MTI. Its CDMO activity offers clinical batch production capacities on several platforms.
5 GMP production platforms for MTI - Production of clinical batches (CSM, CART, iPs, and other lines) - Process development and validation - Regulatory support - QC services
Contact
20 Av du Stade de France
93218 St Denis
France
0155932878
Activities
- Manufacturer
- Service company
- Research structure
- Analytical Process, Quality assement, Quality Control
- CGMP
- Quality control
- Contaminants detection
- CMC
- CMC
- Target Identification
- Target Identification
- Gene Delivery system
- Adeno-Associated Virus (AAV)
- Lipid chemical methods
- Bioproduction
- Bioproduction
- Non-GMP pilot batch
- GMP batch
- Cell acquisition
- Allogenic
- Cell Bank
- Target cell isolation
- Differentiated Cell
- Production Cell
- Safety donor-derived therapies
- Cell modification
- Gene modification
- Cell Expansion
- Cell factory
- Purification / extraction
- Purification / extraction
- Formulation
- Formulation
- Conditionning
- Conditionning
- Analytical Process, Quality assement, Quality Control
- CGMP
- Sterility
- Deviations
- Quality control
- Contaminants detection
- CMC
- CMC
- Gene modification
- Gene modification
- Gene Delivery system
- Lentivirus
- Retrovirus
- CAR Construction
- Intracellular Domain
- T-cell activation/transduction
- Engineering : Tandem CAR
- Engineering : iCAR
- Engineering : Ab-coupled TCR (ATCR)
- Bioproduction
- Bioproduction
- Scale-Up
- Automate manufacturing
- Supply chain logistics
- Tracking process
- Monitoring logistics
- Non-GMP pilot batch
- GMP batch
- Ex Vivo & In Vivo Strategy
- Ex Vivo & In Vivo Strategy
- Cell acquisition
- Apheresis
- Target cell isolation
- Differentiated Cell
- Production Cell
- Safety donor-derived therapies
- Cell modification
- Gene modifcation
- Construct introduction
- Cell Expansion
- Bioreacteur
- Formulation
- Formulation
- Conditionning
- Conditionning
- Transport
- Transport
- Analytical Process, Quality assement, Quality Control
- Cleaning
- CGMP
- Sterility
- Deviations
- Quality control
- Contaminants detection
- CMC
- CMC
- Bioproduction
- Bioproduction
- Scale-Up
- Automate manufacturing
- Supply chain logistics
- Tracking process
- Monitoring logistics
- Non-GMP pilot batch
- GMP batch
- Ex Vivo & In Vivo Strategy
- Ex Vivo & In Vivo Strategy
- Cell acquisition
- Autologus
- Allogenic
- Cell Bank
- Tissue acquisition
- Off the shelf
- Apheresis
- Target cell isolation
- Differentiated Cell
- Production Cell
- Safety donor-derived therapies
- Cell Expansion
- Bioreacteur
- Wave
- Cell factory
- Other
- Purification / extraction
- Purification / extraction
- Conditionning
- Conditionning
